Myoblast transplantation for heart failure
- PMID: 11214133
- DOI: 10.1016/S0140-6736(00)03617-5
Myoblast transplantation for heart failure
Abstract
Intramyocardial skeletal muscle transplantation has been shown experimentally to improve heart function after infarction. We report success with this procedure in a patient with severe ischaemic heart failure. We implanted autologous skeletal myoblasts into the postinfarction scar during coronary artery bypass grafting of remote myocardial areas. 5 months later, there was evidence of contraction and viability in the grafted scar on echocardiography and positron emission tomography. Although this result is encouraging, it requires validation by additional studies.
Similar articles
-
[Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case].Arch Mal Coeur Vaiss. 2001 Mar;94(3):180-2. Arch Mal Coeur Vaiss. 2001. PMID: 11338251 French.
-
Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.Am Heart J. 2004 Sep;148(3):531-7. doi: 10.1016/j.ahj.2004.03.043. Am Heart J. 2004. PMID: 15389244 Clinical Trial.
-
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.J Am Coll Cardiol. 2003 Apr 2;41(7):1078-83. doi: 10.1016/s0735-1097(03)00092-5. J Am Coll Cardiol. 2003. PMID: 12679204 Clinical Trial.
-
Percutaneous autologous myoblast transplantation in the treatment of post-infarction myocardial contractility impairment--report on two cases.Kardiol Pol. 2003 Dec;59(12):492-501. Kardiol Pol. 2003. PMID: 14724696 Review. English, Polish.
-
[Transplantation of autologous skeletal myoblasts in ischemic cardiac insufficiency].J Soc Biol. 2001;195(1):47-9. J Soc Biol. 2001. PMID: 11530499 Review. French.
Cited by
-
Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial.Stem Cell Res Ther. 2023 Sep 23;14(1):264. doi: 10.1186/s13287-023-03495-1. Stem Cell Res Ther. 2023. PMID: 37740221 Free PMC article. Clinical Trial.
-
Establishment of a protocol to administer immunosuppressive drugs for iPS cell-derived cardiomyocyte patch transplantation in a rat myocardial infarction model.Sci Rep. 2023 Jun 29;13(1):10530. doi: 10.1038/s41598-023-37235-5. Sci Rep. 2023. PMID: 37385993 Free PMC article.
-
Are There Hopeful Therapeutic Strategies to Regenerate the Infarcted Hearts?Korean Circ J. 2023 Jun;53(6):367-386. doi: 10.4070/kcj.2023.0098. Korean Circ J. 2023. PMID: 37271744 Free PMC article. Review.
-
Thermoresponsive mixed polymer brush to effectively control the adhesion and separation of stem cells by altering temperature.Mater Today Bio. 2023 Apr 7;20:100627. doi: 10.1016/j.mtbio.2023.100627. eCollection 2023 Jun. Mater Today Bio. 2023. PMID: 37122838 Free PMC article.
-
A three-dimensional culture system for generating cardiac spheroids composed of cardiomyocytes, endothelial cells, smooth-muscle cells, and cardiac fibroblasts derived from human induced-pluripotent stem cells.Front Bioeng Biotechnol. 2022 Jul 22;10:908848. doi: 10.3389/fbioe.2022.908848. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35957645 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
